That takes Wellhub
The clinician side of the operation is clean
Not Suitable For: Breastfeeding mothers Women during their period Individuals allergic to any vitamins People with cardiovascular issues Individuals under 18 years old
Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin
Safety and Side Effects: What Early Studies Reveal While effective, GLP-1 therapies can cause side effects such as nausea, bloating, or fatigue during the adjustment phase
Alaska, Alabama, Arkansas, DC, Delaware, Kansas, Louisiana, Mississippi, North Dakota, New Mexico, Rhode Island, South Dakota, Vermont, West Virginia, and Wyoming are all excluded